Managing Risks to Improve Health Outcomes: How to Move Population Health Forward in an Era of Uncertainty

At the Canadian Association for Population Therapeutics (CAPT) Annual Conference, Sumeet Singh, Senior Director, EVERSANA, delivered a presentation on pharmacoeconomic analysis and outcome-based agreements and what they mean for Canadian private payers.

Watch his session below for answers to the following questions:

  • Are pharmacoeconomic analyses relevant for private payers?
  • Should pharmacoeconomic analyses for private payers differ from those for HTA/public payers?
  • Should a societal or health system perspective be considered at all by private payers?

Author Team
no-image

EVERSANA employs a team of over 2500 professionals across 27 locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…